Discontinuation report KEYTRUDA
Report ID | 72658 |
Drug Identification Number | 02441152 |
Brand name | KEYTRUDA |
Common or Proper name | pembrolizumab for injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | Pembrolizumab |
Strength(s) | 50MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 50 mg |
ATC code | L01XC |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-12-20 |
Actual discontinuation date | 2019-12-05 |
Remaining supply date | 2019-12-04 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-16 | English | Compare |
v2 | 2019-01-16 | French | Compare |
v3 | 2019-02-27 | English | Compare |
v4 | 2019-02-27 | French | Compare |
v5 | 2019-06-28 | English | Compare |
v6 | 2019-06-28 | French | Compare |
v7 | 2019-09-25 | English | Compare |
v8 | 2019-09-25 | English | Compare |
v9 | 2019-09-25 | French | Compare |
v10 | 2019-12-04 | English | Compare |
v11 | 2019-12-04 | English | Compare |
v12 | 2019-12-04 | French | Compare |
v13 | 2019-12-06 | French | Compare |
Showing 1 to 13 of 13